These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 25560648)

  • 1. Nanostructured lipid carriers as novel drug delivery system for lung cancer gene therapy.
    Han Y; Li Y; Zhang P; Sun J; Li X; Sun X; Kong F
    Pharm Dev Technol; 2016; 21(3):277-81. PubMed ID: 25560648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transferrin-modified nanostructured lipid carriers as multifunctional nanomedicine for codelivery of DNA and doxorubicin.
    Han Y; Zhang Y; Li D; Chen Y; Sun J; Kong F
    Int J Nanomedicine; 2014; 9():4107-16. PubMed ID: 25187713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted lung cancer therapy: preparation and optimization of transferrin-decorated nanostructured lipid carriers as novel nanomedicine for co-delivery of anticancer drugs and DNA.
    Shao Z; Shao J; Tan B; Guan S; Liu Z; Zhao Z; He F; Zhao J
    Int J Nanomedicine; 2015; 10():1223-33. PubMed ID: 25709444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung cancer gene therapy: Transferrin and hyaluronic acid dual ligand-decorated novel lipid carriers for targeted gene delivery.
    Zhang B; Zhang Y; Yu D
    Oncol Rep; 2017 Feb; 37(2):937-944. PubMed ID: 27959442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-delivery of plasmid DNA and doxorubicin by solid lipid nanoparticles for lung cancer therapy.
    Han Y; Zhang P; Chen Y; Sun J; Kong F
    Int J Mol Med; 2014 Jul; 34(1):191-6. PubMed ID: 24804644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Which one performs better for targeted lung cancer combination therapy: pre- or post-bombesin-decorated nanostructured lipid carriers?
    Du J; Li L
    Drug Deliv; 2016 Jun; 23(5):1799-809. PubMed ID: 26455787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transferrin- and folate-modified, double-targeted nanocarriers for gene delivery.
    Jing F; Li D; Xu W; Liu Y; Wang K; Sui Z
    Pharm Biol; 2014 May; 52(5):570-4. PubMed ID: 24256214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual ligands modified double targeted nano-system for liver targeted gene delivery.
    Jing F; Li J; Liu D; Wang C; Sui Z
    Pharm Biol; 2013 May; 51(5):643-9. PubMed ID: 23527957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A promising targeted gene delivery system: folate-modified dexamethasone-conjugated solid lipid nanoparticles.
    Wang W; Zhou F; Ge L; Liu X; Kong F
    Pharm Biol; 2014 Aug; 52(8):1039-44. PubMed ID: 24611745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung cancer combination therapy: co-delivery of paclitaxel and doxorubicin by nanostructured lipid carriers for synergistic effect.
    Wang Y; Zhang H; Hao J; Li B; Li M; Xiuwen W
    Drug Deliv; 2016 May; 23(4):1398-403. PubMed ID: 26079530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined using of paclitaxel and salinomycin active targeting nanostructured lipid carriers against non-small cell lung cancer and cancer stem cells.
    Zhou J; Sun M; Jin S; Fan L; Zhu W; Sui X; Cao L; Yang C; Han C
    Drug Deliv; 2019 Dec; 26(1):281-289. PubMed ID: 30880491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transferrin-PEG-PE modified dexamethasone conjugated cationic lipid carrier mediated gene delivery system for tumor-targeted transfection.
    Wang W; Zhou F; Ge L; Liu X; Kong F
    Int J Nanomedicine; 2012; 7():2513-22. PubMed ID: 22679364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel.
    Liu D; Liu Z; Wang L; Zhang C; Zhang N
    Colloids Surf B Biointerfaces; 2011 Jul; 85(2):262-9. PubMed ID: 21435845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Docetaxel-loaded ultrasmall nanostructured lipid carriers for cancer therapy: in vitro and in vivo evaluation.
    Li M; Pei J; Ma Z; Fu J; Chen F; Du S
    Cancer Chemother Pharmacol; 2020 Apr; 85(4):731-739. PubMed ID: 32146495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-delivery of etoposide and curcumin by lipid nanoparticulate drug delivery system for the treatment of gastric tumors.
    Jiang H; Geng D; Liu H; Li Z; Cao J
    Drug Deliv; 2016 Nov; 23(9):3665-3673. PubMed ID: 27749102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery.
    Li H; Chen M; Su Z; Sun M; Ping Q
    Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and evaluation of lipoprotein resembling curcumin-encapsulated protein-free nanostructured lipid carrier for brain targeting.
    Meng F; Asghar S; Xu Y; Wang J; Jin X; Wang Z; Wang J; Ping Q; Zhou J; Xiao Y
    Int J Pharm; 2016 Jun; 506(1-2):46-56. PubMed ID: 27094357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?
    Qu J; Zhang L; Chen Z; Mao G; Gao Z; Lai X; Zhu X; Zhu J
    Drug Deliv; 2016 Nov; 23(9):3408-3416. PubMed ID: 27181462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small peptide-modified nanostructured lipid carriers distribution and targeting to EGFR-overexpressing tumor in vivo.
    Han C; Li Y; Sun M; Liu C; Ma X; Yang X; Yuan Y; Pan W
    Artif Cells Nanomed Biotechnol; 2014 Jun; 42(3):161-6. PubMed ID: 23731383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanostructured lipid carriers for site-specific drug delivery.
    Khosa A; Reddi S; Saha RN
    Biomed Pharmacother; 2018 Jul; 103():598-613. PubMed ID: 29677547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.